Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sawickifor the Diabetes Treatment, P.
Right arrow Articles by Programmes Working Group, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawickifor the Diabetes Treatment, P.
Right arrow Articles by Programmes Working Group, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 9 1890-1899, Copyright © 1997 by Oxford University Press


ORIGINAL ARTICLES

Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimes

P Sawickifor the Diabetes Treatment and T Programmes Working Group
Department of Metabolic Diseases and Nutrition, Heinrich-Heine University, PO Box 10 10 07; D-40001 Dusseldorf, Germany; Corresponding author

Objectives. We investigated the effect of achieved continuos tight blood pressure control and intensified insulin therapy on the rate of progression of renal failure in patients with overt diabetic nephropathy and already impaired renal function. Design and setting. Prospective, randomized, multicentre, follow-up study. Patients and interventions. From a screened group of the 66 hypertensive type 1 diabetic patients (IDDM) with overt diabetic nephropathy and reduced glomerular filtration rate who participated in two intensified treatment programmes, 39 patients fulfilled the study inclusion criteria and were enrolled into the 2-year follow-up period. The choice of antihypertensive drugs was based on a randomized allocation to open antihypertensive treatments starting with felodipine, metoprolol, or ramipril. Outcome and measures. Progression of renal failure was assessed by measurement of glomerular filtration rate (GFR) by inulin clearance every 6 months. Main results. During the study period mean HbAlc was 8.1±1.6% and the office blood pressure 143±14/88±8 mmHg. The change in GFRinulin (mean and 95% CI) was +1.9 (-2.2 +6.1) ml/min/year. GFR improved in 51%, deteriorated in 39%, and remained stable in 10% of the patients. Conclusions. This study shows that stabilization of glomerular filtration rate, as assessed by inulin clearance, is possible in patients with overt diabetic nephropathy who reach the goals of intensified antihypertensive treatment even if kidney function is already impaired. Keywords: diabetic nephropathy; hypertension; antihypertensive treatment; glycaemic control
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
British Journal of Diabetes & Vascular DiseaseHome page
T. Kaiser, C. Florack, U. Stephan, and P. T Sawicki
Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy? A systematic review of randomised controlled trials
The British Journal of Diabetes & Vascular Disease, July 1, 2003; 3(4): 278 - 281.
[Abstract] [PDF]


Home page
QJMHome page
N. Joss, K.R. Paterson, C.J. Deighan, K. Simpson, and J.M. Boulton-Jones
Diabetic nephropathy: how effective is treatment in clinical practice?
QJM, January 1, 2002; 95(1): 41 - 49.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.